Research has shown that KYN, or its metabolite KYNA, can increase the expression of tumor necrosis factor-stimulated gene 6 protein (TSG-6) in human muscle satellite cells (hMuSCs), thereby exerting anti-inflammatory effects and alleviating symptoms of IBD (90). Here, TNFAIP6 is linked to inflammatory bowel disease.